The Layman's Guide to Surviving Cancer: From Diagnosis Through Treatment and Beyond
Unfortunately, Pfizer announced that its drug for late stage lung cancer treatment, Dacomitnib, failed in two late-stage studies. Another stage is set to be reported in 2015. See the report on this development at http://finance.yahoo.com/news/pfizer-cancer-drug-fails-2-133921000.html.
Howard Bressler was diagnosed with Acute Promyelocytic Leukemia (“APL”) in August 2000. During his subsequent treatments, through his bouts with Stevens Johnson Syndrome and in the course of researching and writing his forthcoming book, Howard tapped into much of what he has learned from his experiences and here, he explains these issues in layman's terms and hopes this to be a place where you can come and gain some insight, discuss treatment options and your own issues in facing this disease.